BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32476381)

  • 1. LINC00662 promotes glycolysis and cell survival by regulating miR- 375/HIF-1α axis in ovarian cancer.
    Tao LM; Gong YF; Yang HM; Pei JH; Zhao XJ; Liu SS
    J Biol Regul Homeost Agents; 2020; 34(3):467-477. PubMed ID: 32476381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of long intergenic non-coding RNA LINC00662 contributes to malignant growth of acute myeloid leukemia cells by upregulating ROCK1 via sponging microRNA-340-5p.
    Liu Y; Gao X; Tian X
    Eur J Pharmacol; 2019 Sep; 859():172535. PubMed ID: 31306637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA LINC00504 regulates the Warburg effect in ovarian cancer through inhibition of miR-1244.
    Liu Y; He X; Chen Y; Cao D
    Mol Cell Biochem; 2020 Jan; 464(1-2):39-50. PubMed ID: 31691157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-671-5p reduces tumorigenicity of ovarian cancer via suppressing HDAC5 and HIF-1α expression.
    Peng D; Wu T; Wang J; Huang J; Zheng L; Wang P; Li J; Wu L; Luo M
    Chem Biol Interact; 2022 Mar; 355():109780. PubMed ID: 34990588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non‑coding RNA NEAT1 modifies cell proliferation, colony formation, apoptosis, migration and invasion via the miR‑4500/BZW1 axis in ovarian cancer.
    Xu H; Sun X; Huang Y; Si Q; Li M
    Mol Med Rep; 2020 Oct; 22(4):3347-3357. PubMed ID: 32945505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA LINC01125 Enhances Cisplatin Sensitivity of Ovarian Cancer via miR-1972.
    Guo J; Pan H
    Med Sci Monit; 2019 Dec; 25():9844-9854. PubMed ID: 31865363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA SCAMP1 Targets miR-137/CXCL12 Axis to Boost Cell Invasion and Angiogenesis in Ovarian Cancer.
    Song R; Liu Z; Lu L; Liu F; Zhang B
    DNA Cell Biol; 2020 Jun; 39(6):1041-1050. PubMed ID: 32401536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer.
    Yang Q; Yu Y; Sun Z; Pan Y
    Biomed Pharmacother; 2018 Oct; 106():61-67. PubMed ID: 29957467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-induced up-regulation of miR-27a promotes paclitaxel resistance in ovarian cancer.
    Feng L; Shen F; Zhou J; Li Y; Jiang R; Chen Y
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32190895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA LINC00662 functions as miRNA sponge to promote the prostate cancer tumorigenesis through targeting miR-34a.
    Li N; Zhang LY; Qiao YH; Song RJ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3688-3698. PubMed ID: 31114993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA H19 promotes glioma angiogenesis through miR-138/HIF-1α/VEGF axis.
    Liu ZZ; Tian YF; Wu H; Ouyang SY; Kuang WL
    Neoplasma; 2020 Jan; 67(1):111-118. PubMed ID: 31777264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel lncRNA, Lnc-OC1, promotes ovarian cancer cell proliferation and migration by sponging miR-34a and miR-34c.
    Tao F; Tian X; Lu M; Zhang Z
    J Genet Genomics; 2018 Mar; 45(3):137-145. PubMed ID: 29576507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of a novel circulatory RNA-based biomarker panel expression in ovarian cancer.
    El-Shal AS; Matboli M; Abdelaziz AM; Morsy AA; Abdelbary EH
    IUBMB Life; 2019 Dec; 71(12):2031-2047. PubMed ID: 31520466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma.
    Tan H; Zhao L
    J Cell Biochem; 2019 Apr; 120(4):6502-6514. PubMed ID: 30485482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC00662 promotes cell proliferation, migration and invasion of melanoma by sponging miR-890 to upregulate ELK3.
    Xia XQ; Lu WL; Ye YY; Chen J
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8429-8438. PubMed ID: 32894549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA CTSLP8 mediates ovarian cancer progression and chemotherapy resistance by modulating cellular glycolysis and regulating c-Myc expression through PKM2.
    Li X; Zhang Y; Wang X; Lin F; Cheng X; Wang Z; Wang X
    Cell Biol Toxicol; 2022 Dec; 38(6):1027-1045. PubMed ID: 34510316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
    Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
    Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF-1α Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27a.
    Zhao Q; Li Y; Tan BB; Fan LQ; Yang PG; Tian Y
    PLoS One; 2015; 10(8):e0132746. PubMed ID: 26292288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non‑coding RNA OIP5‑AS1 facilitates the progression of ovarian cancer via the miR‑128‑3p/CCNG1 axis.
    Liu Y; Fu X; Wang X; Liu Y; Song X
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway.
    Wang A; Jin C; Li H; Qin Q; Li L
    Int J Biol Macromol; 2018 Dec; 120(Pt B):1705-1713. PubMed ID: 30268751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.